Related Experiment Videos
Nitric oxide induces apoptosis via triggering mitochondrial permeability transition
S Hortelano1, B Dallaporta, N Zamzami
1CNRS-UPR420, Villejuif, France.
FEBS Letters
|June 30, 1997
Summary
Nitric oxide (NO) triggers apoptosis by initiating mitochondrial permeability transition. This process releases factors that cause DNA damage and cell death, a mechanism preventable with specific inhibitors.
Area of Science:
- Cell Biology
- Immunology
- Neuroscience
Background:
- Nitric oxide (NO) is known to induce apoptosis across various cell types, including immune cells and neurons.
- The precise molecular mechanisms by which NO triggers apoptosis are still under investigation.
Purpose of the Study:
- To elucidate the role of mitochondrial permeability transition in nitric oxide-induced apoptosis.
- To identify the key signaling events downstream of NO exposure that lead to programmed cell death.
Main Methods:
- Investigated the effects of NO on isolated mitochondria and intact thymocytes.
- Utilized inhibitors of mitochondrial permeability transition, such as bongkrekic acid and N-methyl-Val-4-cyclosporin A.
- Assessed markers of apoptosis, including mitochondrial potential disruption, reactive oxygen species generation, phosphatidylserine exposure, and nuclear DNA fragmentation.
Main Results:
- Nitric oxide efficiently induces mitochondrial permeability transition, leading to the release of apoptogenic factors.
- In thymocytes, NO disrupts mitochondrial membrane potential, increases reactive oxygen species, and causes phosphatidylserine externalization.
- Inhibitors of mitochondrial permeability transition blocked NO-induced apoptosis, including DNA fragmentation and phosphatidylserine exposure.
Conclusions:
- Nitric oxide-induced apoptosis is mediated by the triggering of mitochondrial permeability transition.
- Mitochondrial permeability transition is a critical upstream event in the NO-induced apoptotic pathway.
- Targeting mitochondrial permeability transition may offer therapeutic strategies for conditions involving NO-mediated cell death.